Semaglutide may raise risk for nonarteritic anterior ischemic optic neuropathy in diabetes
For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA Ophthalmology.